-The United Nations Elephant poaching levels are the worst in a decade and recorded ivory seizures are at their highest levels since 1989, according to a report published today by the United Nations-backed convention on endangered species. “We need to enhance our collective efforts across range, transit and consumer states to reverse the current disturbing trends in elephant poaching and ivory smuggling,” the Secretary-General of the Convention on International Trade in Endangered...

-The Economic Times A growing number of countries are adopting India's intellectual property regulations, which give enough flexibility to local companies to produce generic versions of popular drugs to safeguard public health. Although multinational companies have criticised India for being lax in enforcing intellectual property (IP) laws, countries such as China, Argentina and the Philippines are adopting similar provisions. Last month, China amended its IP laws, allowing local companies to produce low-cost versions...

-The United Nations World leaders, along with thousands of participants from governments, the private sector, non-governmental organizations (NGOs) and other groups will come together in Rio de Janeiro, Brazil, to take part in the UN Conference on Sustainable Development (Rio+20) later this month. The Conference seeks to shape how countries and their citizens can reduce poverty, advance social equity and ensure environmental protection to achieve long-term growth. Seven key areas have been identified...

-The Economic Times   Pushed to the wall by an overly cautious drug regulator and an alarmist Indian government, clinical trial companies are looking at South East Asian countries to expand their business and escape the red tape of Indian authorities.  Clinical research companies (CROs), that were aspiring to become billion- dollar companies by 2010, had to rework their plans after a Parliamentary Standing Committee report questioned the allegedly unfair and unethical trials...

-The Hindu The World Health Organisation (WHO) has put in place a mechanism to define counterfeit medical products. The set of definitions of sub-standard, spurious, falsely labelled, falsified and counterfeit products will be globally accepted and help to bring about uniformity in identifying such drugs, without interrupting worldwide supplies. The decision to establish a member state mechanism was taken at the World Health Assembly, the WHO's policymaking body, at a meeting held recently. The...